<div id="readability-page-1"><div>Altman Peter Chief Executive Officer of BioCardia Inc [BCDA] filed a Form 4 on December 10, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:<div><table><tbody><tr><th>Date</th><th>Transaction</th><th>Shares</th><th>Price</th><th>Value</th></tr><tr><td>12/8/25</td><td>Exercise</td><td>106,588</td><td>$0.00</td><td>N/A</td></tr><tr><td>12/8/25</td><td>Surrender(1)</td><td>56,484</td><td>$1.37</td><td>$77,383</td></tr></tbody></table></div>Ending Holdings: 266,866 - Direct<ul><li>(1)</li><li>Surrender of shares back to company to pay option exercise cost and/or resulting tax liability.</li></ul>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data. </div></div>

BCDA

CEO Altman of BioCardia Inc acquired 50,104 shares, as disclosed in a Form 4 filed with the SEC. The transaction included exercising 106,588 shares and surrendering 56,484 shares to cover option exercise costs and tax liabilities. Ending holdings are 266,866 shares directly. The Washington Service offers insider trading analysis and data services.

CEO Altman Acquires 50,104 Of BioCardia Inc [BCDA]